Related references
Note: Only part of the references are listed.Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis
Lingdi Yin et al.
CLINICAL CANCER RESEARCH (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications
Tony C. Y. Pang et al.
PANCREATOLOGY (2021)
Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma
Gehan Botrus et al.
ONCOLOGIST (2021)
Preoperative CTC-Detection by CellSearch(R) Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
Harald Hugenschmidt et al.
CANCERS (2021)
Molecular Approaches Using Body Fluid for the Early Detection of Pancreatic Cancer
Kennichi Satoh
DIAGNOSTICS (2021)
LINC00460 promotes pancreatic cancer progression by sponging miR-491-5p
Jiali Wu et al.
JOURNAL OF GENE MEDICINE (2021)
Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer
Cheng Peng et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
Performance of candidate urinary biomarkers for pancreatic cancer Correlation with pancreatic cyst malignant progression?
Michele T. Yip-Schneider et al.
AMERICAN JOURNAL OF SURGERY (2020)
Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma
Shulin Yu et al.
GUT (2020)
Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
Makoto Sugimori et al.
CANCER SCIENCE (2020)
Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer
Kenji Takahashi et al.
CANCER SCIENCE (2020)
Thermophoretic Detection of Exosomal microRNAs by Nanoflares
Junxiang Zhao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
Michael J. Pishvaian et al.
LANCET ONCOLOGY (2020)
Diagnostic value of various liquid biopsy methods for pancreatic cancer A systematic review and meta-analysis
Yuzhou Zhu et al.
MEDICINE (2020)
miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma
Naohiko Yoshizawa et al.
ONCOLOGY LETTERS (2020)
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer
Martin Metzenmacher et al.
CANCERS (2020)
Comparison of methods for miRNA isolation and quantification from ovine plasma
Kathryn Wright et al.
SCIENTIFIC REPORTS (2020)
CA19-9 for detecting recurrence of pancreatic cancer
Azadeh Azizian et al.
SCIENTIFIC REPORTS (2020)
Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients
Nidhi Singh et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
The Serum MicroRNA Signatures for Pancreatic Cancer Detection and Operability Evaluation
Qiuliang Yan et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic Adenocarcinoma
Jean-Baptiste Bachet et al.
CLINICAL CANCER RESEARCH (2020)
Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer
Feng Cao et al.
CLINICAL EPIGENETICS (2020)
Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
Marta Toledano-Fonseca et al.
CANCERS (2020)
MicroRNAs from Liquid Biopsy Derived Extracellular Vesicles: Recent Advances in Detection and Characterization Methods
Rares Drula et al.
CANCERS (2020)
Clinical Perspective and Translational Oncology of Liquid Biopsy
Diego Fernandez-Lazaro et al.
DIAGNOSTICS (2020)
Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application
Melinda Szilagyi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance
Tetsuhiro Okada et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers
Karolina Elzbieta Kaczor-Urbanowicz et al.
PANCREAS (2020)
A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study
Silvana Debernardi et al.
PLOS MEDICINE (2020)
OPENchip: an on-chip in situ molecular profiling platform for gene expression analysis and oncogenic mutation detection in single circulating tumour cells
Amos C. Lee et al.
LAB ON A CHIP (2020)
Application of liquid biopsy for surgical management of pancreatic cancer
Minako Nagai et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases
Ashton A. Connor et al.
CANCER CELL (2019)
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Klaus Pantel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
Vincent P. Groot et al.
CLINICAL CANCER RESEARCH (2019)
Technologies for circulating tumor cell separation from whole blood
Petra Banko et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2019)
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
B. Lee et al.
ANNALS OF ONCOLOGY (2019)
Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma
Hiroyuki Terasawa et al.
CANCER BIOLOGY & THERAPY (2019)
Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
Jee-Soo Lee et al.
MOLECULAR ONCOLOGY (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma
Etienne Buscail et al.
CANCERS (2019)
Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer
Orazio Fortunato et al.
CANCERS (2019)
Liquid biopsies in pancreatic cancer
Nabiollah Kamyabi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement
Douglas K. Owens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine
Claudio Luchini et al.
CANCERS (2019)
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
Consuelo Amantini et al.
FRONTIERS IN ONCOLOGY (2019)
Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer
Sumitra Mohan et al.
SCIENTIFIC REPORTS (2019)
High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery
Etienne Buscail et al.
CANCERS (2019)
KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients
Zhe-Ying Wang et al.
FRONTIERS IN ONCOLOGY (2019)
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Vincent Bernard et al.
GASTROENTEROLOGY (2019)
Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients
Sachiyo Kawamura et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2019)
Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer
Tao Wei et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA
Susana Junqueira-Neto et al.
ACTA CYTOLOGICA (2019)
Next-generation sequencing in liquid biopsy: cancer screening and early detection
Ming Chen et al.
HUMAN GENOMICS (2019)
Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
Julia Mayerle et al.
GUT (2018)
An amplification-free electrochemical detection of exosomal miRNA-21 in serum samples
Kseniia Boriachek et al.
ANALYST (2018)
Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?
Jin He et al.
ANNALS OF SURGERY (2018)
Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer
Colin M. Court et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring
Myron G. Best et al.
CANCER RESEARCH (2018)
Borderline resectable pancreatic cancer. Challenges and controversies
Luis Sabater et al.
CANCER TREATMENT REVIEWS (2018)
Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma
Min Kyeong Kim et al.
CLINICAL CHEMISTRY (2018)
The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis
Lois A. Daamen et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial.
Geertjan Van Tienhoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma
Kunihiko Takahasi et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2018)
Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer
Lois A. Daamen et al.
HPB (2018)
Liquid biopsy in pancreatic cancer: the beginning of a new era
Dipesh Kumar Yadav et al.
Oncotarget (2018)
Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection
Petr Karasek et al.
CANCER GENOMICS & PROTEOMICS (2018)
Blood-Derived microRNAs for Pancreatic Cancer Diagnosis: A Narrative Review and Meta-Analysis
Xiaodong Li et al.
FRONTIERS IN PHYSIOLOGY (2018)
Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer
S. Kruger et al.
ANNALS OF ONCOLOGY (2018)
Pancreatic cancer circulating tumor cells: applications for personalized oncology
Benjamin J. DiPardo et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer
Detlef K. Bartsch et al.
JOURNAL OF CLINICAL MEDICINE (2018)
DEPArray™ system: An automatic image-based sorter for isolation of pure circulating tumor cells
Mariano Di Trapani et al.
CYTOMETRY PART A (2018)
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shu Yi Shen et al.
NATURE (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status Results of the Prospective CLUSTER Study
Georgios Gemenetzis et al.
ANNALS OF SURGERY (2018)
Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma
Katherine E. Poruk et al.
CLINICAL CANCER RESEARCH (2017)
Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
Daniel Pietrasz et al.
CLINICAL CANCER RESEARCH (2017)
Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients
He Cheng et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk
Yong Cui et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Early detection of pancreatic cancer: Where are we now and where are we going?
Bin Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer
Yu Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
Alvin P. Makohon-Moore et al.
NATURE GENETICS (2017)
Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing
Anders Stahlberg et al.
NATURE PROTOCOLS (2017)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Joshua D. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
A signal-amplifiable biochip quantifies extracellular vesicle-associated RNAs for early cancer detection
Jiaming Hu et al.
NATURE COMMUNICATIONS (2017)
Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
Eveline E. Vietsch et al.
CANCER GENETICS (2017)
Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
Birte Kulemann et al.
SCIENTIFIC REPORTS (2017)
The Exosome Total Isolation Chip
Fei Liu et al.
ACS NANO (2017)
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
David Sefrioui et al.
BRITISH JOURNAL OF CANCER (2017)
Platelet RNA signatures for the detection of cancer
Nik Sol et al.
CANCER AND METASTASIS REVIEWS (2017)
Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma
Han Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Clinical impact of circulating tumor cells and therapy response in pancreatic cancer
K. Okubo et al.
EJSO (2017)
Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers
Kunitoshi Shigeyasu et al.
CLINICAL CANCER RESEARCH (2017)
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer
Xianyin Lai et al.
CANCER LETTERS (2017)
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients
K. Allenson et al.
ANNALS OF ONCOLOGY (2017)
Exodisc for Rapid, Size-Selective, and Efficient Isolation and Analysis of Nanoscale Extracellular Vesicles from Biological Samples
Hyun-Kyung Woo et al.
ACS NANO (2017)
More deaths from pancreatic cancer than breast cancer in the EU by 2017
J. Ferlay et al.
ACTA ONCOLOGICA (2016)
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
ANNALS OF SURGERY (2016)
Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
Naoto Hadano et al.
BRITISH JOURNAL OF CANCER (2016)
Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
J. S. Ankeny et al.
BRITISH JOURNAL OF CANCER (2016)
Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis
Ting Deng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer
Nora Brychta et al.
CLINICAL CHEMISTRY (2016)
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
Sebastian Moran et al.
LANCET ONCOLOGY (2016)
A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer A High Portal Venous CTC Count Predicts Liver Metastases
Yu Wen Tien et al.
MEDICINE (2016)
Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma
Efrat Dotan et al.
PANCREAS (2016)
A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancer
Jing Yang et al.
PANCREATOLOGY (2016)
Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis
Tatsuo Hata et al.
PANCREATOLOGY (2016)
Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues
Jeffrey D. Krimmel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids
Taisuke Imamura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer
Zijun Xie et al.
ONCOTARGET (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report
Piotr Hogendorf et al.
CANCER BIOMARKERS (2016)
Biotin-Triggered Decomposable lmmunomagnetic Beads for Capture and Release of Circulating Tumor Cells
Ning-Ning Lu et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining
Daniel E. Campton et al.
BMC CANCER (2015)
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
Mahito Miyamae et al.
BRITISH JOURNAL OF CANCER (2015)
Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer
Hideaki Kinugasa et al.
CANCER (2015)
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
Myron G. Best et al.
CANCER CELL (2015)
Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma
Shuhei Komatsu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound
Daniel V. T. Catenacci et al.
GASTROENTEROLOGY (2015)
Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings
Christy E. Cauley et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sonia A. Melo et al.
NATURE (2015)
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
Mark Sausen et al.
NATURE COMMUNICATIONS (2015)
Salivary microRNAs Show Potential as a Noninvasive Biomarker for Detecting Resectable Pancreatic Cancer
Zijun Xie et al.
CANCER PREVENTION RESEARCH (2015)
Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity
Bindhu Madhavan et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer
Yujuan Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
Erina Takai et al.
SCIENTIFIC REPORTS (2015)
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F. Rothe et al.
ANNALS OF ONCOLOGY (2014)
Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies
R. Roy et al.
BRITISH JOURNAL OF CANCER (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Pharmacogenomic Modeling of Circulating Tumor and Invasive Cells for Prediction of Chemotherapy Response and Resistance in Pancreatic Cancer
Kenneth H. Yu et al.
CLINICAL CANCER RESEARCH (2014)
Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions
Andrew D. Rhim et al.
GASTROENTEROLOGY (2014)
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
Sandra S. McAllister et al.
NATURE CELL BIOLOGY (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Microfluidic, marker-free isolation of circulating tumor cells from blood samples
Nezihi Murat Karabacak et al.
NATURE PROTOCOLS (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
MicroRNA-196a and-196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer
Emily P. Slater et al.
TRANSLATIONAL ONCOLOGY (2014)
Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis
Lu Han et al.
TUMOR BIOLOGY (2014)
Reproducible extracellular vesicle size and concentration determination with tunable resistive pulse sensing
Frank A. W. Coumans et al.
JOURNAL OF EXTRACELLULAR VESICLES (2014)
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial
F. C. Bidard et al.
ANNALS OF ONCOLOGY (2013)
Pancreatic Ductal Adenocarcinoma is Associated with a Distinct Urinary Metabolomic Signature
Vanessa W. Davis et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
T. Kawaguchi et al.
BRITISH JOURNAL OF CANCER (2013)
Role of Pancreatic Cancer-derived Exosomes in Salivary Biomarker Development
Chang Lau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
NanoVelcro Chip for CTC enumeration in prostate cancer patients
Yi-Tsung Lu et al.
METHODS (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma
Risheng Que et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
ApoStream™, a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood
Vishal Gupta et al.
BIOMICROFLUIDICS (2012)
Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by 1H Nuclear Magnetic Resonance: Identification, Mapping, and Evolution
Claudia Napoli et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Cancer stem cells: an evolving concept
Long V. Nguyen et al.
NATURE REVIEWS CANCER (2012)
Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy
Chuanli Ren et al.
CANCER BIOLOGY & THERAPY (2011)
A filtration-based protocol to isolate human Plasma Membrane-derived Vesicles and exosomes from blood plasma
Ryan Grant et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Salivary Transcriptomic Biomarkers for Detection of Resectable Pancreatic Cancer
Lei Zhang et al.
GASTROENTEROLOGY (2010)
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody
Jason P. Gleghorn et al.
LAB ON A CHIP (2010)
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L. Stott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Beyond Clotting: The Powers of Platelets
Mitch Leslie
SCIENCE (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Follow-Up Study of K-ras Mutations in the Plasma of Patients With Pancreatic Cancer Correlation With Clinical Features and Carbohydrate Antigen 19-9
Jan Daebritz et al.
PANCREAS (2009)
Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device
AmirAli H. Talasaz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor
Andre A. Adams et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation
Xiaodong Tong et al.
EXPERIMENTAL HEMATOLOGY (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins
Jun Adachi et al.
GENOME BIOLOGY (2006)
Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood
R Rosenberg et al.
CYTOMETRY (2002)
Differential diagnosis between chronic pancreatitis and pancreatic cancer:: value of the detection of KRAS2 mutations in circulating DNA
F Maire et al.
BRITISH JOURNAL OF CANCER (2002)
MethyLight: a high-throughput assay to measure DNA methylation
Cindy A. Eads et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
